Recent advances of upconversion nanoparticles in theranostics and bioimaging applications
- Authors
- Rafique, Rafia; Kailasa, Suresh Kumar; Park, Tae Jung
- Issue Date
- Nov-2019
- Publisher
- Elsevier B.V.
- Keywords
- Cancer therapy; Drug delivery; In vitro and in vivo studies; Optical properties; Surface chemistry; Upconversion nanoparticles
- Citation
- TrAC - Trends in Analytical Chemistry, v.120
- Journal Title
- TrAC - Trends in Analytical Chemistry
- Volume
- 120
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/38860
- DOI
- 10.1016/j.trac.2019.115646
- ISSN
- 0165-9936
1879-3142
- Abstract
- In recent years, upconversion nanoparticles (UCNPs) have attracted considerable research interest because of their unique optical merits (unique optical merits: sharp emissions, large anti-Stokes shifts, long lifetimes, and negligible photobleaching) that make them as ideal candidates for unified applications in biomedical fields including drug delivery, bioimaging, and cancer therapy. In this review, we illustrate the recent efforts on fabrication of UCNPs with organic, inorganic and biomolecules that create UCNPs as the next generation biomedical agents for drug delivery and cancer therapy. The introduction summarizes the recent developments and uses of UCNPs in analytical and biomedical research areas. We discuss the optical properties and the surface modifications of UCNPs and their synergistic theranostic applications in cancer therapies (chemo and photothermal) in vivo and in vitro studies. Further, we also discuss the cytotoxicity of UCNPs. Finally, the prospects and future challenges of UCNPs in drug delivery, bioimaging and cancer therapy are described. © 2019 Elsevier B.V.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Natural Sciences > Department of Chemistry > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/38860)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.